5-Hydroxy Saxagliptin-¹³C,d₂ (hydrochloride)

Cat. No.: HY-144199S: Fiche technique Instruction de manipulation
FAQs
Technical Support

5-Hydroxy Saxagliptin-¹³C,d₂ (hydrochloride) is the ¹³C- and deuterium labeled 5-Hydroxy Saxagliptin.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

5-Hydroxy Saxagliptin-<sup>13</sup>C,d<sub>2</sub> (hydrochloride)

5-Hydroxy Saxagliptin-¹³C,d₂ (hydrochloride) Chemical Structure

Size	Stock	Quantité
1 mg	Obtenir un devis 2 - 3 Weeks 1 - 2 Weeks 3 - 4 Weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
5 mg	Obtenir un devis
10 mg	Obtenir un devis

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Avis client

Based on 1 Customer Validation

Recommandations en vedette

•Related Small Molecules:

•Related Proteins:

Activité biologique
Pureté et documentation
Références
Avis client

Description	5-Hydroxy Saxagliptin-¹³C,d₂ (hydrochloride) is the ¹³C- and deuterium labeled 5-Hydroxy Saxagliptin^[1].
Application	1. This compound can be used as a tracer. 2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[16]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 5-Hydroxy Saxagliptin-¹³C,d₂ (hydrochloride) Related Antibodies
Masse moléculaire	370.88
Formule	C₁₇¹³CH₂₄D₂ClN₃O₃
Unlabeled CAS	841302-24-7
SMILES	O[C@@]12C[C@@](C[C@@H]3C2)(O)C[C@@](C3)([C@H](N)[13C](N4[C@@]5([H])C([2H])([2H])[C@@]5([H])C[C@H]4C#N)=O)C1.Cl
Livraison	Room temperature in continental US; may vary elsewhere.
Stockage	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation	Fiche technique (272 KB) Instruction de manipulation (2659 KB)
Références	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]